Literature DB >> 21550972

L-threonine regulates G1/S phase transition of mouse embryonic stem cells via PI3K/Akt, MAPKs, and mTORC pathways.

Jung Min Ryu1, Ho Jae Han.   

Abstract

Although amino acids can function as signaling molecules in the regulation of many cellular processes, mechanisms surrounding L-threonine involvement in embryonic stem cell (ESC) functions have not been explored. Thus, we investigated the effect of L-threonine on regulation of mouse (m)ESC self-renewal and related signaling pathways. In L-threonine-depleted mESC culture media mRNA of self-renewal marker genes, [(3)H]thymidine incorporation, expression of c-Myc, Oct4, and cyclins protein was attenuated. In addition, resupplying L-threonine (500 μM) after depletion restores/maintains the mESC proliferation. Disruption of the lipid raft/caveolae microdomain through treatment with methyl-β-cyclodextrin or transfection with caveolin-1 specific small interfering RNA blocked L-threonine-induced proliferation of mESCs. Addition of L-threonine induced phosphorylation of Akt, ERK, p38, JNK/SAPK, and mTOR in a time-dependent manner. This activity was blocked by LY 294002 (PI3K inhibitor), wortmannin (PI3K inhibitor), or an Akt inhibitor. L-threonine-induced activation of mTOR, p70S6K, and 4E-BP1 as well as cyclins and Oct4 were blocked by PD 98059 (ERK inhibitor), SB 203580 (p38 inhibitor) or SP 600125 (JNK inhibitor). Furthermore, L-threonine induced phosphorylation of raptor and rictor binding to mTOR was completely inhibited by 24 h treatment with rapamycin (mTOR inhibitor); however, a 10 min treatment with rapamycin only partially inhibited rictor phosphorylation. L-threonine induced translocation of rictor from the membrane to the cytosol/nuclear, which blocked by pretreatment with rapamycin. In addition, rapamycin blocked L-threonine-induced increases in mRNA expressions of trophoectoderm and mesoderm marker genes and mESC proliferation. In conclusion, L-threonine stimulated ESC G(1)/S transition through lipid raft/caveolae-dependent PI3K/Akt, MAPKs, mTOR, p70S6K, and 4E-BP1 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550972      PMCID: PMC3129147          DOI: 10.1074/jbc.M110.216283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Recycling the cell cycle: cyclins revisited.

Authors:  Andrew W Murray
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

3.  Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.

Authors:  Matthew E R Butchbach; Guilian Tian; Hong Guo; Chien-Liang Glenn Lin
Journal:  J Biol Chem       Date:  2004-06-08       Impact factor: 5.157

4.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

5.  L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture.

Authors:  Jennifer M Washington; Joy Rathjen; Fernando Felquer; Ana Lonic; Michael D Bettess; Nancy Hamra; Ljiljana Semendric; Boon Siang Nicholas Tan; Julie-Anne Lake; Rebecca A Keough; Michael B Morris; Peter D Rathjen
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-17       Impact factor: 4.249

6.  Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney.

Authors:  C M Brett; C B Washington; R J Ott; M M Gutierrez; K M Giacomini
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 7.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.

Authors:  Stephen G Dann; Anand Selvaraj; George Thomas
Journal:  Trends Mol Med       Date:  2007-04-23       Impact factor: 11.951

8.  Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells.

Authors:  K Shigemitsu; Y Tsujishita; K Hara; M Nanahoshi; J Avruch; K Yonezawa
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

9.  Nutrient sensing by the early mouse embryo: hexosamine biosynthesis and glucose signaling during preimplantation development.

Authors:  Marie Pantaleon; Jeanie Scott; Peter L Kaye
Journal:  Biol Reprod       Date:  2007-11-28       Impact factor: 4.285

10.  mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.

Authors:  Jiaxi Zhou; Pei Su; Lu Wang; Joanna Chen; Maike Zimmermann; Olga Genbacev; Olubunmi Afonja; Mary C Horne; Tetsuya Tanaka; Enkui Duan; Susan J Fisher; Jiayu Liao; Jie Chen; Fei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

View more
  24 in total

1.  Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids.

Authors:  Laura Novellasdemunt; Irantzu Tato; Aurea Navarro-Sabate; Marisol Ruiz-Meana; Andrés Méndez-Lucas; Jose Carlos Perales; David Garcia-Dorado; Francesc Ventura; Ramon Bartrons; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2013-03-02       Impact factor: 5.157

2.  Glutamine contributes to maintenance of mouse embryonic stem cell self-renewal through PKC-dependent downregulation of HDAC1 and DNMT1/3a.

Authors:  Jung Min Ryu; Sang Hun Lee; Je Kyung Seong; Ho Jae Han
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Akt suppresses DLK for maintaining self-renewal of mouse embryonic stem cells.

Authors:  Cheng-Chung Wu; Hong-Jin Wu; Chia-Hui Wang; Chia-Hua Lin; Shu-Ching Hsu; Yi-Rong Chen; Michael Hsiao; Scott C Schuyler; Frank Leigh Lu; Nianhan Ma; Jean Lu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  JNK-induced apoptosis, compensatory growth, and cancer stem cells.

Authors:  Fei Chen
Journal:  Cancer Res       Date:  2012-01-15       Impact factor: 12.701

Review 5.  Nutrients in the fate of pluripotent stem cells.

Authors:  Vivian Lu; Irena J Roy; Michael A Teitell
Journal:  Cell Metab       Date:  2021-10-12       Impact factor: 27.287

Review 6.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

7.  Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation.

Authors:  Robert L Kortum; Mario R Fernandez; Diane L Costanzo-Garvey; Heidi J Johnson; Kurt W Fisher; Deanna J Volle; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2014-07-07       Impact factor: 4.272

Review 8.  Influence of Amino Acid Metabolism on Embryonic Stem Cell Function and Differentiation.

Authors:  Michael S Kilberg; Naohiro Terada; Jixiu Shan
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

Review 9.  Regulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism.

Authors:  Jung Min Ryu; Hyun Jik Lee; Young Hyun Jung; Ki Hoon Lee; Dah Ihm Kim; Jeong Yeon Kim; So Hee Ko; Gee Euhn Choi; Ing Ing Chai; Eun Ju Song; Ji Young Oh; Sei-Jung Lee; Ho Jae Han
Journal:  Int J Stem Cells       Date:  2015-05       Impact factor: 2.500

10.  Cell-type-specific predictive network yields novel insights into mouse embryonic stem cell self-renewal and cell fate.

Authors:  Karen G Dowell; Allen K Simons; Zack Z Wang; Kyuson Yun; Matthew A Hibbs
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.